Treatment of patients (pts) with chronic myeloid leukemia (CML) and imatinib failure after developing Bcr-Abl kinase mutations with allogeneic stem cell transplantation (ASCT)

被引：0
|
作者：
Jabbour, E [1 ]
Cortes, J [1 ]
De Lima, M [1 ]
Andersson, B [1 ]
Giralt, S [1 ]
Kantarjian, H [1 ]
Champlin, R [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
43
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Treatment of patients (pts) with chronic myeloid leukemia (CML) and imatinib failure after developing BCR-ABL kinase mutations with allogeneic stem cell transplantation (ASCT).
    Champlin, R. E.
    Jabbour, E.
    Cortes, J.
    Kantarjian, H.
    Andersson, B. S.
    Giralt, S.
    De Lima, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 348S - 348S
  • [2] Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure
    Jabbour, Elias
    Cortes, Jorge
    Kantarjian, Hagop M.
    Giralt, Sergio
    Jones, Dan
    Jones, Roy
    Giles, Francis
    Andersson, Borje S.
    Champlin, Richard
    de Lima, Marcos
    BLOOD, 2006, 108 (04) : 1421 - 1423
  • [3] Outcome of salvage therapy in patients (pts) with chronic myeloid leukemia (CML) who failed imatinib after developing BCR-ABL kinase mutation.
    Jabbour, E
    Kantarjian, H
    Talpaz, M
    Jones, D
    O'Brien, S
    Giles, F
    Garcia-Manero, G
    Ravandi, F
    Faderl, S
    Verstovsek, S
    Rios, MB
    Cortes, J
    BLOOD, 2005, 106 (11) : 318A - 318A
  • [4] Results of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Advanced Chronic Myeloid Leukemia (CML) Patients (pts) Who Failed Tyrosine Kinase Inhibitors (TKIs) after Developing BCR-ABL Kinase Domain (KD) Mutations.
    Jabbour, Elias
    Cortes, Jorge
    de Padua Silva, Leandro
    de Lima, Marcos
    Jones, Dan
    O'Brien, Susan
    Rondon, Gabriela
    Popat, Uday
    Giralt, Sergio
    Kantarjian, Hagop
    Champlin, Richard
    BLOOD, 2008, 112 (11) : 358 - 358
  • [5] The Significance of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia
    Goldman, John M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 679 - 680
  • [6] Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib
    Chahardouli, Bahram
    Zaker, Farhad
    Mousavi, Seied Asadollah
    Saffari, Zeinab
    Nadali, Fatemeh
    Ostadali, Mohammadreza
    Ghadimi, Habibeh
    Alimoghaddam, Kamran
    Ghavamzade, Ardeshir
    Rostami, Shahrbano
    HEMATOLOGY, 2013, 18 (06) : 327 - 332
  • [7] Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?
    Yap, E.
    Tumian, N. R.
    Azma, R. Z.
    Sharifah, N. A.
    Salwati, S.
    Hamidah, N. H.
    Elias, M. H.
    Wong, C. L.
    MALAYSIAN JOURNAL OF PATHOLOGY, 2017, 39 (02) : 107 - 113
  • [8] Detection of BCR-ABL point mutations in patients with chronic myeloid leukemia (CML) resistant to imatinib.
    Silveira, Rosana A.
    Albuquerque, Dulcineia M.
    Assis, Angela M.
    Ichihara, Edson
    de Souza, Carmino A.
    Costa, Fernando F.
    Delamain, Marcia T.
    Vigorito, Afonso C.
    Lorand-Metze, Irene
    Miranda, Eliana
    Pagnano, Katia B. B.
    BLOOD, 2006, 108 (11) : 289B - 289B
  • [9] Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia
    Arpinati, Mario
    Tolomelli, Giulia
    Bochicchio, Maria Teresa
    Castagnetti, Fausto
    Amabile, Marilina
    Bandini, Giuseppe
    Bonifazi, Francesca
    Stanzani, Marta
    Rosti, Gianantonio
    Martinelli, Giovanni
    Baccarani, Michele
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 735 - 740
  • [10] BCR-ABL KINASE DOMAIN MUTATION FREQUENCY IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT TO IMATINIB THERAPY
    Tikhonova, V.
    Misyurina, E.
    Kesaeva, L.
    Finashutina, Y.
    Krutov, A.
    Aksenova, E.
    Soldatova, I.
    Soldatkina, O.
    Ivanova, V.
    Novitskaya, N.
    Arshanskaya, E.
    Lazarev, I.
    Volkova, M.
    Pospelova, T.
    Konstantinova, T.
    Vysotskaya, L.
    Voloditcheva, E.
    Lapin, V.
    Davydkin, I.
    Turkina, A.
    Kolosheinova, T.
    Goryacheva, S.
    Chelysheva, E.
    Pristupa, A.
    Golubenko, R.
    Gavrilova, L.
    Volkova, S.
    Kuchma, G.
    Ovsyannikova, E.
    Zaklyakova, L.
    Kaplanov, K.
    Klitochenko, T.
    Misyurin, A.
    HAEMATOLOGICA, 2013, 98 : 548 - 548
12345